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Prenatal ketamine exposure 
causes abnormal development of 
prefrontal cortex in rat
Tianyun Zhao1,*, Chuanxiang Li2,*, Wei Wei1, Haixing Zhang2, Daqing Ma3, Xingrong Song1 & 
Libing Zhou4,5
Ketamine is commonly used for anesthesia and as a recreational drug. In pregnant users, a potential 
neurotoxicity in offspring has been noted. Our previous work demonstrated that ketamine exposure 
of pregnant rats induces affective disorders and cognitive impairments in offspring. As the prefrontal 
cortex (PFC) is critically involved in emotional and cognitive processes, here we studied whether 
maternal ketamine exposure influences the development of the PFC in offspring. Pregnant rats on 
gestational day 14 were treated with ketamine at a sedative dose for 2 hrs, and pups were studied 
at postnatal day 0 (P0) or P30. We found that maternal ketamine exposure resulted in cell apoptosis 
and neuronal loss in fetal brain. Upon ketamine exposure in utero, PFC neurons at P30 showed more 
dendritic branching, while cultured neurons from P0 PFC extended shorter neurites than controls. In 
addition, maternal ketamine exposure postponed the switch of NR2B/2A expression, and perturbed 
pre- and postsynaptic protein expression in the PFC. These data suggest that prenatal ketamine 
exposure impairs neuronal development of the PFC, which may be associated with abnormal behavior 
in offsprings.
Ketamine is widely used clinically for anesthesia, especially in the developing world1. Up to 2% pregnant women 
require surgery, due to problems associated with pregnancy itself or to other medical conditions, and ketamine 
a common choice. This number is increasing, partly because of laparoscopic procedures and fetal surgery2. 
Furthermore, ketamine is a popular drug of abuse in diverse populations including pregnant women in the 
West3,4 and Southeast Asia5. As ketamine may have a prolonged effect on the central nervous system, it is impor-
tant to investigate whether its use in pregnant subjects may affect neurodevelopment of their offspring.
General anesthetics may be toxic to the developing brain6–9, as evidenced by increased apoptotic cells, 
impaired neurogenesis, and neuroinflammation10. In rodents and primates, some anesthetics used in early-life 
might impair cognitive function, an effect that can last into adulthood11,12. These findings are supported by retro-
spective clinical data which indicate that the use of anesthetics during early life may be associated with late-onset 
learning disabilities8,13. Learning and memory function may not be the sole target of toxicity associated with 
anesthetics, and emotional disorders such as depression and anxiety have not been studied.
We previously reported that14, maternal exposure to ketamine for 2 hrs on gestational day 14 induced anx-
iety and depression-like behavior15, and cognitive impairment in offsprings. The mismatched expression of 
N-methyl-D-aspartate (NMDA) receptor subunits and decreased levels of brain-derived neurotrophic factor 
and postsynaptic density-95 protein (PSD-95) may be responsible for the abnormal behavior14. Emotion mod-
ulates memory and learning, interferes with decision making and provides the motivation for critical action16. 
Conversely, cognitive processing is an integral part of emotion: Anxiety and depression lead to information 
processing biases and cognitive dysfunction, which contribute to the onset and/or maintenance of symptoms17. 
Cognition and emotion are intricately intertwined, and both are implemented by overlapping networks in brain 
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regions including the PFC, hippocampus and amygdala18. The hippocampus to PFC pathway plays a critical role 
in learning and memory19. The PFC receives input from all other cortical regions and hippocampus, and mediates 
planning and goal-directed motor, cognitive, and affective behavior20. Compared to other areas, the maturation 
of the PFC is protracted and therefore more susceptible to harmful factors, contributing to neuropsychiatric dis-
orders21. As the abnormal development of the PFC is responsible for diverse emotional, cognitive, and mnemonic 
problems22, we tested whether the maternal exposure to ketamine impacts the development of PFC, and explored 
some potential mechanisms.
At low and subanesthetic doses, ketamine is a selective and potent antagonist of NMDA receptors23. In 
the brain, NMDA receptors are involved in neuronal development and circuit formation by mediating synap-
tic activity, organizing functional circuits and regulating dendritic growth24,25. Two NMDA receptor subunits, 
NR2A and NR2B, have specific effects during dendritic arbor development, and a switch in expression of NR2B 
to NR2A occurs during synaptogenesis25,26. The cytoplasmic C-terminus of NR2A and NR2B interacts with 
membrane-associated guanylate kinase members and PSD-95, which is essential for clustering and anchoring 
NMDA receptors at synapses27,28. In this study, we aimed to test the hypothesis that maternal ketamine expo-
sure may disturb the temporal switch of NR2A/2B subunits and impact dendritic development via the PSD-95/
NR2A/2B-NMDA receptors in the PFC.
Results
Ketamine induces a widespread apoptosis in fetal brain. To assess apoptosis, TUNEL-positive cells 
were counted in different regions 8 hrs after ketamine administration and in control fetuses. The number of 
TUNEL positive cells was significantly larger in the ketamine than in the control group (Fig. 1), particularly in 
the ventral telencephalon (Fig. 1b,e,g, 116 ± 9 cells/mm2 vs. 70 ± 6 cells/mm2, t = 4.199, p = 0.001), hippocampal 
primordium (Fig. 1c,f,h, 82 ± 7 cells/mm2 vs. 60 ± 6 cells/mm2, t = 2.319, p = 0.039) and neocortex (Fig. 1a,d,i, 
26 ± 2 cells/mm2 vs. 20 ± 2 cells/mm2, t = 2.381, p = 0.039). As necrotic cells also contain fragmented DNA and 
TUNEL cannot distinguish between apoptosis and necrosis, we also used anti-activated caspase-3 immunoflu-
orescence to detect apoptotic profiles. We found that positive cells were significantly increased in the ketamine 
compared to the control group (Fig. 2), in the ventral telencephalon (Fig. 2b,e,g, 106 ± 8 cells/mm2 vs. 66 ± 5 
cells/mm2, t = 4.257, p = 0.001), hippocampus primordium (Fig. 2c,f,h, 73 ± 6 cells/mm2 vs. 45 ± 4 cells/mm2, 
t = 4.224, p = 0.001) and neocortex (Fig. 2c,f,i, 21 ± 2 cells/mm2 vs. 15 ± 1 cells/mm2, t = 3.153, p = 0.011).
Figure 1. Ketamine induces a widespread apoptosis in fetal brain. Embryonic day 14 coronal sections were 
stained with TUNEL. In control (a–c) and ketamine (d–f) groups, positive cells were widely distributed in the 
ventral telencephalon (vTel), hippocampal primordium (Hip) and neocortex (NCx). Positive cells in different 
brain areas were significantly increased in the ketamine compared to the control group (g): vTel; (h): Hip;  
(i): NCx). LV, lateral ventricle. * p < 0.05; * * p < 0.01; n = 6 in each group.
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Ketamine causes neuronal loss in laminae II-III of the PFC in offspring. We previously found 
that ketamine-treated offsprings developed mental disorders in adulthood14. As the PFC is a key hub in neu-
ral networks that modulate emotional behavior29, we studied the architecture of the PFC at P0 and P30 using 
Nissl staining. Compared to the control group, cell density in laminae II-III of ketamine-treated offsprings was 
decreased by 14% at P0, and 32% at P30 (Fig. 3b–e,h; t = 2.354, p = 0.040 and t = 2.302, p = 0.044, respectively). 
However, there was no significant difference in cell density in lamina V of the PFC at P0 and P30 (Fig. 3b,c,f,g,i, 
t = 0.628, p = 0.544 and t = 0.645, p = 0.533, respectively). Thus, neurons in laminae II-III appear more suscepti-
ble to ketamine.
Ketamine exposure disturbs the maturation of pyramidal neurons in the PFC of offspring. To 
study pyramidal neurons, we performed Golgi–Cox impregnation and reconstructed basal and apical dendritic 
trees of 120 pyramidal neurons in each group (10 neurons per region and 6 pups per group) selected from lami-
nae II-III and V of the PFC. Basal and apical dendrites, and the total dendritic branch length in neurons of lam-
ina V were similar in the ketamine and control groups (data not shown). In contrast, in laminae II-III, neurons 
from ketamine-treated pups had more basal branches (Fig. 4a–c, n = 6, t = 2.495, p = 0.032) and longer total 
branch length than in the control group (Fig. 4a,b,d, t = 2.370, p = 0.039). This was confirmed by Sholl analysis 
(Fig. 4f, p = 0.009). Furthermore, the spine density was significantly increased in laminae II and III neurons from 
ketamine-treated offsprings compared with that in control samples (Fig. 4a’,b’,e, t = 3.371, p = 0.007).
Ketamine administration inhibits neurite growth in neuronal culture. To verify that anomalies 
of pyramidal neurons in animals exposed to ketamine in utero are due to a cell intrinsic defect, we cultured PFC 
neurons from control and ketamine-treated P0 pups. As shown in Fig. 5, after 4 days in vitro (DIV), neurons 
from both groups were comparable in their ability to extend neurites. However, quantitative analysis showed 
that the total neurite length was significantly shorter and the branching was significantly decreased in the 
ketamine-treated compared to the control group (Fig. 5m,n, t = 2.389, p = 0.020 and t = 2.246, p = 0.029, respec-
tively). Similar results were obtained by Sholl analysis (Fig. 5o, p < 0.01). These data suggested that maternal 
administration of ketamine resulted in a cell autonomous decrease in neurite extension of PFC neurons in vitro.
Expression of NR2B/NR2A, synaptophysin and PSD-95 is affected by maternal exposure of 
ketamine. We measured the expression of NR2B and NR2A, the presynaptic protein synaptophysin and the 
Figure 2. Caspase-3 positive cells in the fetal brain. Embryonic day 14 sections were stained with antibodies 
against cleaved caspase-3. In control (a–c) and ketamine (d–f) groups, positive cells were widely distributed in 
the ventral telencephalon (vTel), hippocampal primordium (Hip) and neocortex (NCx). Their densities were 
significantly increased in the ketamine compared to the control group in different areas ((g) vTel; (h) Hip;  
(i) NCx). LV, lateral ventricle. * p < 0.05; * * p < 0.01; n = 6 in each group.
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Figure 3. Ketamine causes neuronal loss in laminae II-III of the PFC in offspring. Coronal sections 
encompassing the PFC at P0 and P30, stained with cresyl violet. The boxed area indicated in panel a was 
chosen for analysis. At P0, the cytoarchitecture of the PFC was comparable in control (b) and ketamine (c) 
groups, but the cell density in laminae II-III was significantly decreased in the ketamine group (h). At P30, cell 
distribution was similar in laminae II-III (d,e) and V (f,g) of control (d,f) and ketamine-treated animals (e,g). 
In the ketamine group, the cell density was significantly decreased in laminae II-III (h) but not in lamina V (i), 
compared to the control group. PrL, prelimbic cortex; * p < 0.05; n = 6 in each group.
www.nature.com/scientificreports/
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postsynaptic protein PSD-95 in the PFC at P0 and P30 (Fig. 6). The expression of NR2B was significantly higher in 
the control than the ketamine-treated group at P0 (Fig. 6a,c, 0.857 ± 0.038 vs. 0.680 ± 0.040, F = 10.24, p = 0.033). 
In contrast, the situation was different at P30, when NR2B levels were slightly lower in the ketamine than in the 
control group (Fig. 6a,c, the control vs. the ketamine: 0.367 ± 0.066 vs. 0.593 ± 0.044, F = 8.260, p = 0.045). NR2A 
protein was expressed a low level at P0, with no significant difference in the two groups (Fig. 6b,d, 0.287 ± 0.050 
in control vs. 0.247 ± 0.046 in ketamine, F = 0.346, p = 0.588). Interestingly, the NR2A protein level was signifi-
cantly decreased in the ketamine compared to the control at P30 (Fig. 6b,d, ketamine vs. control: 0.427 ± 0.035 vs. 
0.620 ± 0.047, F = 10.745, p = 0.031). The level of synaptophysin was significantly higher in the control than the 
ketamine-treated group at both P0 and P30 (Fig. 6e,g, t = 3.590, p = 0.023 and t = 2.874, p = 0.014, respectively). 
In contrast, PSD-95 was weakly and similarly expressed in both groups at P0, but very significantly higher in 
ketamine-treated rats than control animals at P30 (Fig. 6f,h, t = 4.732, p = 0.009). In addition, to better define the 
distribution and localization of synaptic proteins, we performed double immunofluorescence using anti-PSD-95 
and anti-synaptophysin (SY-38) antibodies on PFC sections from P30 brains. In accord with the results obtained 
with western blot, there was clearly higher fluorescence intensity for PSD-95 and less immunoreactivity of synap-
tophysin in the ketamine group compared to the control (Fig. 7c,d, t = 2.661, p = 0.024 and t = 2.859, p = 0.017, 
respectively).
Figure 4. Ketamine exposure disturbs the maturation of pyramidal neurons in the PFC of offspring.  
Six P30 brains in each group were processed for Golgi–Cox impregnation and pyramidal neurons in laminae 
II-III of the PFC were studied in the control (examples in a) and ketamine (examples in b) groups. The left 
panels of (a,b) show two examples of Golgi-impregnated neurons. The total branch number and dendritic 
length were significantly increased in the ketamine compared to the control group (c,d) n = 60 neurons in each 
group). In addition, the ketamine group had higher spine density than the control (a’, b’, (e) n = 60 dendrites in 
each group). Sholl analysis showed that the complexity of dendritic trees was higher in the ketamine than in the 
control group (f) Kolmogorov–Smirnov test). * p < 0.05; * * p < 0.01.
www.nature.com/scientificreports/
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Discussion
The present study provides evidence that maternal administration of subanesthetic dose of ketamine during 
pregnancy in rats induces apoptosis and neuronal loss in fetal brain, as well as abnormalities of PFC layer II/III 
Figure 5. Ketamine administration in utero inhibits neurite growth in neuronal culture. P0 PFC neurons 
from pups whose mothers received ketamine at gestational day 14 or not (control) (n = 6 in each group) were 
cultured for 4 DIV, immunostained with anti-β-tubulin antibodies (a,b), prior to reconstruction using Imaris 
(examples in (c–g), control; (h–l), ketamine group). Quantitative analysis showed that the total neurite length 
and number were significantly lower in the ketamine than the control groups ((m,n); n = 60 neurons in each 
group). This difference was confirmed by Sholl analysis (o). * p < 0.05; * * p < 0.01.
www.nature.com/scientificreports/
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pyramidal neuron development. In the PFC, there are mismatched expression of NMDA receptor subunits and 
disturbed expression of pre- and postsynaptic proteins at P0 and P30. Together with our previous study, these 
results indicate that in utero ketamine exposure has detrimental effects on brain development, particularly in the 
hippocampus and PFC.
Figure 6. Expression of NR2B/2A, PSD-95 and synaptophysin is affected by maternal exposure to ketamine. 
PFC tissue from P0 and P30 rats were processed for western blots to detect proteins NR2B (a), NR2A (b), 
synaptophysin (SY-38, e) and PSD-95 (f). The NR2B protein levels in the ketamine group were significantly 
lower at P0 and higher at P30 compared to the corresponding control samples (a,c). The NR2A protein was 
expressed at a low level at P0 in both control and ketamine samples (b,d) but was significantly decreased in the 
ketamine compared to the control at P30 (b,d). The ketamine group expressed significantly less SY-38 at P0 and 
P30 relatively to controls (e,g). In contrast, there was no significant difference of PSD-95 levels at P0 and more 
PSD-95 protein in the ketamine group than in the control at P30 (f,h). ctrl-P0, control group at P0; ctrl-P30, 
control group at P30; ktm-P0, the ketamine group at P0; ktm-P30, ketamine group at P30. * p < 0.05; * * p < 0.01, 
comparison between the control and ketamine group; #p < 0.05; ##p < 0.01, comparison between P0 and P30; 
n = 6 in each group.
www.nature.com/scientificreports/
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Anesthetics can be toxic for the developing brain, and two critical factors determine neurotoxicity: the stage 
of brain development at which the compound is administered, and the dose and/or duration of exposure30. 
Neurodevelopment proceeds at a different pace in different brain regions, so that vulnerability depends both on 
stage and region. Although the dose in our experiment was subanesthetic, sedative dose23 could induce cell apop-
tosis in fetal brain. This is consistent with a previous observation that ketamine exposure of fetal rhesus monkeys 
resulted in 2.2 times more neuronal loss than exposure at early postnatal stages6. Our data confirm that fetal 
brains are more vulnerable to ketamine than neonatal ones, with preferential neuronal loss in laminae II and III of 
PFC region. We previously showed that ketamine administration in utero impaired postnatal neurogenesis in the 
dentate gyrus and in the subventricular zone. It is therefore likely that ketamine induced neuronal loss by impact-
ing the proliferation and/or apoptosis of neural progenitor cells, which remains to be demonstrated further.
The hippocampus and PFC play well-established roles in cognitive and mnemonic processes. Psychiatric 
disorders, such as schizophrenia, depression and post-traumatic stress syndrome, share common symptoms of 
cognitive impairment and emotional dysregulation and are associated with structural and pathophysiological 
changes in the hippocampus and PFC31. Our previous study showed that ketamine exposure impaired matu-
ration of pyramidal cells in the CA3 hippocampal field of offspring (at P30)14. In contrast, the present study 
Figure 7. The numbers of PSD-95 and synaptophysin positive cells in PFC are modified by ketamine exposure. 
The rat with location of the medial prefrontal cortex (PrL, a). Areas of prefrontal cortex as indicated in (b) and 
laminae II-III as indicated in (e–h) were selected for analysis. Paraffin coronal sections from P30 PFC were stained 
with anti-PSD-95 and anti-synatophysin (SY-38) antibodies. Fluorescent immunohistochemistry for PSD-95 (green) 
and SY-38 (green), and DAPI (blue). The signal was estimated by quantifying the density of immnofluorescence 
using Image J. The ketamine group showed a significant increase of PSD-95 immunoreactivity (c) and a significant 
decrease of synaptophysin (d) at P30 compared to the control. * p < 0.05; n = 6 in each group.
www.nature.com/scientificreports/
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shows that pyramidal neurons in laminae II and III of the PFC of offspring (at P30) harbor the opposite profiles, 
exhibiting more branched and longer basilar dendrites, and increased spine density after ketamine exposure. 
This discrepancy is likely due to regional differences of anaesthesia-induced neurotoxic effect on synaptogenesis 
and neuroplasticity32. Moreover, our data are consistent with reports that psychoactive drugs such as ampheta-
mine, cocaine or nicotine, increased spine density in PFC and nucleus accumbens33,34. For layer II/III cells, basal 
dendrites receive inputs from local sources and apical dendrites receive inputs from other cortical areas as well 
as nonspecific thalamic inputs35,36. Our results indicates that exposure of ketamine in utero may influence local 
synaptic circuits in PFC in adulthood.
In addition to inducing apoptosis, anesthetics interfere with synaptogenesis37,38. Most excitatory inputs are 
targeted to dendrites and the establishment of dendritic trees is a highly dynamic process characterized by exten-
sion and retraction of branches, followed by their stabilization and establishment of synaptic connections39. We 
investigated dendritic development at two developmental time points, early (cultured PFC neurons at P0) and 
mature stages (P30, Golgi staining). In cultured neurons derived from neonatal PFC, the total neurite length was 
significantly shorter and neurites less ramified in the ketamine than in the control group. This is consistent with a 
previous observations that ketamine induced neuronal damage in rat primary forebrain cultures40. Intriguingly, 
our in vivo data at P30 showed an opposite over-branched dendritic phenotype upon ketamine exposure. A 
possible explanation is that PFC neurons at P0 are at an early stage of dendritic development, characterized by 
dynamic branch extension, and this may be dampened by ketamine treatment. In contrast, neurons at P30 are at 
the end of those dynamic processes, when the overall effect of ketamine could result in dendritic over-branching. 
Given that Golgi impregnation does not work well at P0, other techniques, such as electron microscopy and 
electrophysiology-coupled imaging are required to test that hypothesis.
NMDA receptors are important for neuronal development and circuit formation24. The NR2B subunit is 
highly expressed in the embryonic and neonatal brain, whereas expression of the NR2A subunit increases dur-
ing brain maturation41. This ‘developmental switch’ of the subunit content of synaptic NMDA receptors plays a 
key role in refining topographic projections, organizing functional circuits and regulating dendritic growth26. In 
control animals, we found that NR2B was abundantly expressed at P0 and significantly decreased at P30, while 
NR2A was expressed at a low level at P0 and significantly increased at P30, as reported42. However, the reduction 
of NR2B protein at P30 and the increase of NR2A expression were not as prominent in ketamine treated neurons. 
This blunted ‘developmental switch’ of NR2B/NR2A expression induced by ketamine may cause the impaired 
dendritic development of PFC neurons, and may be involved in the behavioral phenotype in offsprings. NMDA 
receptors are predominantly expressed at the postsynaptic membrane where they interact with components of the 
postsynaptic density that modulate their activity, particularly PSD-9543. PSD-95 regulates the size and strength 
of synapses44, the formation of synaptic assemblies45, and spine-maturation46. Synaptophysin is one of the most 
abundant synaptic vesicle integral proteins that regulates the formation and trafficking of synaptic vesicles47. 
Our Western blot and immunohistochemistry data showed that the expression of PSD-95 and synaptophysin at 
P0 and P30 was similar to what was reported elsewhere48,49. The higher levels of PSD-95 and NR2B expression 
in ketamine-treated than in the control samples presumably reflects increased synapse concentration, which is 
consistent with the overbranched dendritic phenotype in mature neurons39. The decreased expression of synap-
tophysin at P0 and P30 may reflect abnormal transmitter release in ketamine-treated offsprings.
In summary, together with our previous study14 , the present results show that exposure to ketamine in utero 
can impair the development of the hippocampus and the PFC, both of which might contribute to cognitive 
impairment and mood disorders in offspring. This information has important implications for the use of keta-
mine in anesthesia and as a recreational drug, especially during pregnancy.
Materials and Methods
Subjects. All experimental procedures were performed according to the guidelines that have been approved 
by the Ethics Committees of Jinan University, Guangzhou, China. The Sprague-Dawley rats, weighted 180–220 g, 
were housed with a 12 hr light/dark cycle and had access to water and food ad libitum. The vaginal plugs were 
checked in the morning and a positive one was defined as the gestational day 0. Ketamine injections were done 
on gestational day 14.
Anesthesia. On gestational day 14, 18 dams were randomly divided into control (n = 9) and ketamine (n = 9) 
groups. The establishment of animal models was described before14. Three dams per group were used for TUNEL 
assay 8 hrs after ketamine infusion whilst another six in each group were allowed to give birth naturally. Three 
P0 pups from each dam were used for neuronal culture and each experiment was repeated six times. P0 and 
P30 brains were used for histology and western blot. Golgi stain was carried out on P30 brains. A schematic 
representation of experimental protocols is shown in Fig. 8. The total dose of ketamine used in each dam was 
144.2 ± 4.6 mg/kg (n = 9), and all anesthetized dams recovered fully without complications, such as respiratory 
depression, cardiac arrest, or miscarriage. The recovery time from anesthesia was 37 ± 4 min (n = 9), and the total 
anesthesia time (from initial intramuscular injection to recovery) was 176 ± 4 min. At P30, the body weight of rats 
in the ketamine group was less than that of the control group (71 ± 3 g vs. 88 ± 3 g; t = 3.770, p = 0.0003).
Histology and immunohistochemistry. Ten paraffin coronal sections (5 μ m) including the PFC 
(+ 2.7 mm from bregma and + 3.7 mm from interaural landmark) were stained with 0.5% cresyl violet (n = 6 in 
each pup). Microphotographs were taken under a 40× objective (Leica, DM6000B, Germany). Nissl-stained cell 
numbers were counted in a blinded manner using Image J. (NIH, USA). For Immunohistochemistry, the sections 
were incubated with the following primary antibodies overnight at 4 °C: goat anti-cleaved caspase-3 antibody 
(L-18) (1:250, Cat.No.sc-1225, Santa Cruz, CA, Germany), mouse anti-Synaptophysin (1:1000, Cat.No.ab8049, 
Abcam, Cambridge, UK), mouse- anti-PSD-95 (1:1000, Cat.No. MAB1596, Millipore, USA). Signal was detected 
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with Alexafluor 546- or 488-labeled fluorescent secondary antibodies (1:1000, Invitrogen, Carlsbad, CA, USA). 
Caspase-3 positive cells and PSD-95 and synaptophysin immunofluorescence intensity were evaluated using 
Image J (NIH, USA).
TUNEL analysis. Eight hrs after ketamine infusion, embryonic brains were fixed in 4% paraformaldehyde 
(PFA) overnight at 4 °C, then processed and embedded in wax. Ten to fifteen paraffin coronal sections (5 μ m) of 
each brain (n = 6, 2 from each dam) were stained with a TUNEL kit (C1086, Beyotime institute of Biotechnology, 
China). Positive cells were examined under the microscope with a digital camera system (Leica).
Golgi stain. Golgi stain, tri-dimensional reconstruction and dendrite analysis were performed as described14. 
Frozen brain sections with 150 μ m-thickness between + 2.7 mm from bregma and + 3.7 mm from interaural land-
mark were stained using a FD Rapid Golgi Stain kit (FD NeuroTechnologies, Inc. Columbia, USA) and 10 well 
individualized pyramidal neurons in superficial (II–III) and deep (V) laminaes were reconstructed using with 
the Imaris software (BitPlane AG, Zurich, Switzerland). To measure spine density, distal segments of dendrites of 
pyramidal neurons selected for reconstruction were photographed using a 100× objective for counting of spines 
in 40 μ m segments, and the results were expressed as the number of spines /10 μ m.
Neuronal cultures and neurite analysis. Cerebral cortices from PFC were chopped into pieces and 
digested with 0.25% trypsin (w/v) in HBSS at 37 °C for 30 min. The reaction was stopped by fetal bovine serum 
(Cat.No.10099133, Gibco). Samples were triturated by gentle pipetting and cells were harvested by centrif-
ugation at 1000 rpm for 5 min, and seeded on polylysine-coated coverslips at a density of 1.0 × 105 cells/ml. 
The culture medium was neurobasal-A medium (Cat.No.10888022, Invitrogen) supplemented with 2% B27 
(Cat.No.17504044, Invitrogen). After 4 DIV, cells were fixed with 4% PFA and immunostained with rabbit 
anti-β-tubulin (1:1000, Cat.No.2128, Cell Signaling Technology). The images of 10 well developed neurons were 
captured and neurites were analyzed using the Imaris software (BitPlane AG). The complexity of total dendritic 
trees was estimated using Sholl analysis50.
Western blotting. Samples from PFC (n = 6/group) were dissociated in lysis buffer (containing protease 
inhibitors, 50 mM Tris–HCl, pH 7.6) on ice for 30 min and homogenized via ultrasonification (Ningbo scientz 
biotechnology CO. LTD, Ningbo, China). After centrifugation at 12,000 g for 10 min at 4 °C, supernatants were 
pooled and protein concentrations were measured with a BCA assay kit (Beyotime Institute of Biotechnology, 
China). Thirty μ g protein samples were mixed with gel loading buffer (50 mM Tris-HCl, 10% SDS, 10% glycerol, 
10% 2-mercaptoethanol, 2 mg/ml bromophenol blue) in a 1:1 ratio, boiled for 5 min and subjected to SDS-PAGE 
gels. The separated proteins were transferred to polyvinylidene fluoride membranes and incubated with mouse 
anti-Synaptophysin (1:1000, Cat.No.ab8049, Abcam, Cambridge, UK), rabbit anti-NR2B (1:1000, Cat.No.06-600, 
Millipore, USA), rabbit anti-NR2A (1:1000, Cat.No.4205, Cell Signaling Technology, USA), mouse anti-PSD-95 
(1:1000, Cat.No.MAB1596, Millipore, USA), rabbit anti-GAPDH (1:1000, Cat.No.5174, Cell Signaling 
Technology, USA) and rabbit anti-β-tubulin (1:1000, Cat.No.2128, Cell Signaling Technology, USA) overnight 
at 4 °C. Signal was detected using HRP-conjugated rabbit or mouse antibodies followed by chemiluminescence 
using a Super Signal West Pico kit (Pierce) and Hyper film ECL (Amersham Biosciences). All experiments were 
carried out at least in triplicate. Autoradiography films were scanned and signals were quantified using Image J 
(NIH, USA). Density of each band was normalized to reference controls (β-tubulin or GAPDH).
Statistical analysis. Data were presented as mean ± SEM. The homogeneity of variance was verified with 
Levene’s test and single comparison between both groups was made using unpaired two-tailed Student t test. Data 
on expression of NR2B and NR2A were analyzed by two-way ANOVA, and significant main effects of two differ-
ent timepoints were followed by one-way ANOVA for each group. The parametric Bonferroni and nonparametric 
Kruskal–Wallis H tests were used to analyze dendrite branching with the Sholl method. Results were considered 
significant (* or #) at p < 0.05 and highly significant (* * or # #) at p < 0.01. All analyses were performed using SPSS 
16.0 software (SPSS Inc., Chicago, IL, USA).
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